Dehaier Medical Systems : Showcasesits Wearable Sleep Respiratory SolutionatJiangxi Sleep an

Dehaier Medical Systems Showcasesits Wearable Sleep Respiratory SolutionatJiangxi Sleep and Health F

BEIJING, January 22 , 2015 -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM )("Dehaier" or the "Company"), which develops, markets andsells medical devices and wearablesleep respiratory products in China, today announced that representatives from the Company recently participated in the JiangxiProvince Sleep and Health Forum (the "Jiangxi Sleep Forum") to promote the Company'swearable sleep respiratory product and solution .

Hosted bythe Jiangxi Science and Technology Association and the Jiangxi Sleep Medical Association, the Jiangxi Sleep Forum brought together over 100 attendeesfrom leading hospitals, businesses, government, and academiato discuss thelatest advances in respiratory care and sleep medicine, includingobstructivesleep apnea syndrome (OSAS) diagnosis and treatment. The Company's wearablesleep respiratory solution systems were featured at the Jiangxi Sleep Forum andgarnered positive reviews from attending sleep experts from leading hospitalsincluding the Departments of Neurology and Cardiology of the Second AffiliatedHospital of Nanchang University (SAHNU) and the Affiliated Hospital of JiujiangCollege.

According to epidemiological statistics, approximately 25% of people aged40 years and over suffer from OSAS in China, and over 5% of people aged 40years and over suffer from severe OSAS symptoms. Patients with cardiovascularand cerebrovascular diseases have a particularly high rate of OSAS, which canbe as high as 70-80% for patients with refractory hypertension and cerebralstroke. Conversely, the rate of hypertension for patients with severe OSASsymptoms is 60 times higher than that for people without OSAS. As hypertensioncan also lead to heart diseases and cerebral stroke, OSAS, hypertension,cerebralstroke and heart diseases can create a vicious circle that exacerbates symptomsof these diseases.China has approximately 50 million people with OSAS symptoms,making China one of the world's largest OSAS markets.

Ms. Reyna Dong, Marketing Director of Dehaier's Sleep RespiratoryProducts Division stated, "As we continue to heighten our sales and marketingefforts with significant investments in expansion of direct salesrepresentatives and third-party agents, we also view conferences and forums asimportant venues to raise the awareness for our innovative sleep respiratorysolution systems among respiratory care and sleep professionals whose academicauthority and influence can facilitate our market development. We view theJiangxi market as one of the key regions for our sleep respiratory business.While we already cooperate with SAHNU for a pilot sleep screening program for cerebralstrokes, we believe the Jiangxi Sleep Forum provides us with an important venueto showcase our wearable sleep respiratory product systems and help toaccelerate our penetration of the Jiangxi market."

Ms. Dong continued, "China's wearable medical devices market is projectedto reach RMB 5.0 billion by 2017 with chronic disease care and diagnosis togrow the fastest and to account for approximately 80% of the market by 2017.This favorable market trend gives us a significant tailwind for our sleeprespiratory business in years to come."

AboutDehaier Medical Systems Ltd.

Dehaier is anemerging leader in the development, marketing and sale of medical products,including medical devices and wearable sleep respiratory products. The companydevelops and assembles its self-branded medical devices and sleep respiratoryproducts from third-party components. The company also distributes productsdesigned and manufactured by other companies, including medical devices fromIMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based onsix patents and eleven software copyrights. More information may be found at http://www.dehaier.com.cn.

Forward-lookingStatements

Thisnews release contains forward-looking statements as defined by the PrivateSecurities Litigation Reform Act of 1995. Forward-looking statements includestatements concerning plans, objectives, goals, strategies, future events orperformance, and underlying assumptions and other statements that are otherthan statements of historical facts. These statements are subject touncertainties and risks including, but not limited to, product and servicedemand and acceptance, fulfillment of bids and contracts, changes intechnology, economic conditions, the impact of competition and pricing,government regulation, and other risks contained in reports filed by thecompany with the Securities and Exchange Commission. All such forward-lookingstatements, whether written or oral, and whether made by or on behalf of thecompany, are expressly qualified by the cautionary statements and any othercautionary statements which may accompany the forward-looking statements. Inaddition, the company disclaims any obligation to update any forward-lookingstatements to reflect events or circumstances after the date hereof.

For more information,please contact:

Dehaier MedicalSystems Limited

JaniceWang

[phone]

[e-mail]

Weitian InvestorRelations

TinaXiao

[phone]

[e-mail]